Xbrane Biopharma AB (publ) (XBRANE.ST)
SEK 0.16
(-3.53%)
SEK 0.16
(-3.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 238.72 Million | 57.61 Million | 11.53 Million | 6.82 Million | 600 Thousand | 112.95 Million |
| Cost of Revenue | 203.34 Million | 16.57 Million | 12.21 Million | 4.37 Million | 18.27 Million | 15.9 Million |
| Gross Profit | 35.38 Million | 41.04 Million | -684 Thousand | 2.45 Million | -17.67 Million | 97.04 Million |
| Operating Expenses | 357.62 Million | 210.27 Million | 191.93 Million | 231.07 Million | 140.28 Million | 107.51 Million |
| Selling, General and Administrative Expenses | 40.03 Million | 31.53 Million | 31.39 Million | 31.18 Million | 26.86 Million | 24.28 Million |
| Research and Development Expenses | 305.78 Million | 199.64 Million | 160.61 Million | 203.3 Million | 115.71 Million | 85.82 Million |
| Other Expenses | 11.8 Million | -20.91 Million | -84 Thousand | -3.41 Million | -2.29 Million | -466 Thousand |
| Cost and Expenses | 560.96 Million | 210.27 Million | 191.93 Million | 231.07 Million | 158.55 Million | 123.42 Million |
| Operating Income | -310.42 Million | -166.21 Million | -180.39 Million | -224.25 Million | -164.62 Million | -11.41 Million |
| Interest Expense | 2.27 Million | 2.58 Million | 2.63 Million | 766 Thousand | 1.45 Million | 1.74 Million |
| Income Tax Expense | - | 3.71 Million | 7.78 Million | 766 Thousand | 1.43 Million | 121 Thousand |
| Earnings before Tax | -322.02 Million | -168.51 Million | -183.22 Million | -226.02 Million | -166.03 Million | -13.11 Million |
| Net Income | -388.17 Million | -172.22 Million | -191.01 Million | -226.79 Million | -167.47 Million | -13.23 Million |
| Earnings Per Share Basic | -1.27 | -0.77 | -0.90 | -1.41 | -1.90 | -0.23 |
| Earnings Per Share Diluted | -1.27 | -0.77 | -0.90 | -1.41 | -1.90 | -0.23 |
| Weighted Average Shares Outstanding | 253.2 Million | 225.55 Million | 208.11 Million | 159.77 Million | 98.71 Million | 57.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 253.2 Million | 225.55 Million | 208.11 Million | 159.77 Million | 98.71 Million | 57.81 Million |
| Gross Margin | 0.15 | 0.71 | -0.06 | 0.36 | -29.45 | 0.86 |
| EBIT Margin | -1.18 | -2.88 | -14.53 | -32.06 | -262.12 | -0.05 |
| Profit Margin | -1.63 | -2.99 | -16.56 | -33.25 | -279.12 | -0.12 |
| EBITDA | -282.03 Million | -149.34 Million | -167.59 Million | -213.06 Million | -179.99 Million | -7.04 Million |
| Earnings Before Tax Margin | -1.30 | -2.88 | -15.64 | -32.88 | -274.37 | -0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 66.81 Million | 52 Million | 14.06 Million | 66.89 Million | 238.72 Million | 58.89 Million |
| Cost of Revenue | 22.16 Million | -13.38 Million | 13.85 Million | 62.65 Million | 224.77 Million | 54.73 Million |
| Gross Profit | 44.65 Million | 65.38 Million | 217 Thousand | 4.23 Million | 13.95 Million | 4.15 Million |
| Operating Expenses | 82.07 Million | 129.08 Million | 89.49 Million | 87.48 Million | 324.38 Million | 93.86 Million |
| Selling, General and Administrative Expenses | 9.71 Million | 9.31 Million | 1.86 Million | 8.49 Million | - | 8.23 Million |
| Research and Development Expenses | 72.58 Million | 116.31 Million | 87.62 Million | 78.98 Million | - | 81.54 Million |
| Other Expenses | -226 Thousand | -23.31 Million | - | - | - | - |
| Cost and Expenses | 104.23 Million | 115.7 Million | 103.34 Million | 150.14 Million | 549.15 Million | 148.6 Million |
| Operating Income | -37.42 Million | -63.66 Million | -89.27 Million | -83.24 Million | -310.42 Million | -89.71 Million |
| Interest Expense | 7.39 Million | 6.53 Million | 11.96 Million | 6.11 Million | 18.5 Million | - |
| Income Tax Expense | 520 Thousand | 302 Thousand | 299 Thousand | 64.89 Million | 66.14 Million | 283 Thousand |
| Earnings before Tax | -44.82 Million | -70.2 Million | -97.1 Million | -92.64 Million | -322.02 Million | -80.94 Million |
| Net Income | -45.11 Million | -70.5 Million | -97.4 Million | -157.53 Million | -388.17 Million | -81.23 Million |
| Earnings Per Share Basic | -0.03 | -0.05 | -0.30 | -0.60 | - | -0.31 |
| Earnings Per Share Diluted | -0.03 | -0.05 | -0.30 | -0.60 | - | -0.31 |
| Weighted Average Shares Outstanding | 1.52 Billion | 1.52 Billion | 324.61 Million | 262.93 Million | 253.2 Million | 257.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.52 Billion | 1.52 Billion | 324.61 Million | 262.93 Million | 253.2 Million | 257.9 Million |
| Gross Margin | 0.67 | 1.26 | 0.02 | 0.06 | 0.06 | 0.07 |
| EBIT Margin | -0.56 | -1.22 | -5.70 | -0.99 | - | -1.52 |
| Profit Margin | -0.68 | -1.36 | -6.92 | -2.35 | -1.63 | -1.38 |
| EBITDA | -37.42 Million | -63.66 Million | -80.17 Million | -65.96 Million | - | -89.71 Million |
| Earnings Before Tax Margin | -0.56 | -1.22 | -6.35 | -1.24 | -1.30 | -1.52 |
MTGRF
AFP
3591
DCTH
2266
002736